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ABSTRACT 
Objective: To formulate and evaluate floating in situ gel of Ranitidine using natural polymers like sodium alginate and pectin and calcium carbonate 
as cross-linking agent.  
Methods: The in situ gel was prepared by mixing sodium alginate (SA), calcium carbonate, sodium citrate and ranitidine. The formulated in situ gel 
was evaluated for physicochemical parameters, In vitro buoyancy study and In vitro release study.  
Results: The In vitro drug release profile demonstrated the positive effect of concentration of both sodium alginate (SA) and Calcium Carbonate on 
comparing various formulations. It was also found that the ratio of SA and CaCO3 also affects the release pattern. The drug release pattern from the 
formulations was found to follow Fickian diffusion of the drug. 
Conclusion: With the suitable concentration of SA and CaCO3, the sustained release of the drug can be achieved by in situ gel along with good 
floating properties. Thus, this approach provides a potential development of sustained release floating in situ system of the liquid preparations. 
Keywords: In situ gel, Floating drug delivery, Sodium alginate, Pectin, Calcium carbonate, Ranitidine.  
 
INTRODUCTION 
An in situ gel drug delivery is a novel idea of delivering drugs as a 
liquid dosage. Yet achieves sustained release of drug [1]. The in situ 
gel delivery systems are advantageous because of ease of 
administration and the reduced frequency of administration, 
improved patient compliance, sustained drug release [2].  In situ gel 
delivery systems are in solution form before administration in the 
body, but once administered, they undergo gelation in situ to form a 
gel. Gastro retentive in situ gelling system helps to increase 
bioavailability of the drug as compared to conventional liquid 
dosage form. The gel formed from in situ gelling system, being 
lighter than gastric fluids, floats over the stomach contents and 
produces gastric retention of dosage form and increases gastric 
residence time resulting in prolonged drug delivery in 
gastrointestinal tract [3].  
Ranitidine is a H2 receptor antagonist used in the treatment of 
gastric and duodenal ulceration and gastro-oesophageal reflux 
disease. It is absorbed from the gastrointestinal tract with the 
bioavailability of about 50% and an elimination half-life of 3 hours. 
Patients with reflux esophagitis being treated with proton pump 
inhibitor may continue to produce acid in the night and thus could 
be benefited by taking a sustained release formulation of H2 receptor 
antagonist. Several approaches are currently used to prolong gastric 
retention time [4]. Among them, the principle of floating in situ gel 
system is a simple approach to achieve increased gastric residence 
time for the dosage form and sustain the drug release.  
In this study, an attempt was made to prepare a formulation of 
ranitidine as in situ gel forming drug delivery system to sustain the 
release of drug. The polymers sodium alginate and pectin were used 
as gel forming polymer and calcium carbonate as a cross linking 
agent. The screening of these two polymers was done by employing 
Plackett and Burman design for the design of the experiment. 
MATERIALS AND METHODS 
Materials 
Ranitidine Hydrochloride and Ranitidine Hydrochloride working 
standard were received from Chemi drugs Pvt. Ltd, Kathmandu, 
Nepal as gift samples. Sodium alginate and Calcium carbonate were 
obtained from the Department of Pharmacy, Kathmandu University, 
Dhulikel Nepal. Sodium citrate was received from Qmed 
formulations Pvt. Ltd. Pectin was purchased from the local supplier. 
Methodology 
Preparation of in situ gel 
The solutions of sodium alginate and pectin, alone, or in combination 
in different concentrations were made in deionized water, in which 
0.25% w/v sodium citrate was previously dissolved. The solution 
was heated to 60°C with constant stirring on a magnetic stirrer. It 
was then allowed to cool to 40°C and calcium carbonate in different 
concentration was dispersed in the previous solution with 
continuous stirring. Ranitidine hydrochloride was then added to the 
resulting solution with continuous stirring. The solution was then 
stored in amber colored bottles. 
Experimental design 
Preliminary trials 
The trials were conducted using different gelling agents like sodium 
alginate and pectin in different concentrations. The different types of 
cross-linking agents like calcium carbonate, calcium chloride and 
sodium bicarbonate were used for trials. The formulations were 
evaluated on the basis of gel formation and floating properties. 
Plackett-burman formulation design 
After selection of excipients from experimental trials, the factorial 
design was used for screening of the excipients by applying Plackett-
Burman formulation design in Minitab 16. Sodium alginate 0.5 to 3% 
w/v and Pectin 1.5 to 3% w/v were used as gelling agent and 
calcium carbonate 0.25 to 1% w/v was used as cross-linking agent 
as shown in Table 1. 
Central composite formulation design 
After Statistical interpretation of data obtained from Plackett-Burman 
formulation, Sodium alginate 0.5 to 3% w/v and Calcium carbonate 
0.25 to 2% w/v were selected as gelling agent and cross-linking agent 
respectively to design Central Composite formulation in Minitab 16. 
Twelve formulations were obtained as shown in Table 2. 
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Table 1: Factorial design of formulations by applying Plackett-Burman Formulation design 






12 1 1 1 0.5 1.5 0.25 103.64 
5 2 1 1 3.0 3.0 0.25 88.06 
9 3 1 1 0.5 1.5 0.25 101.32 
6 4 1 1 3.0 3.0 1.00 83.04 
4 5 1 1 3.0 1.5 1.00 105.54 
7 6 1 1 0.5 3.0 1.00 102.43 
10 7 1 1 3.0 1.5 0.25 100.97 
11 8 1 1 0.5 3.0 0.25 99.07 
8 9 1 1 0.5 1.5 1.00 99.24 
3 10 1 1 0.5 3.0 1.00 107.25 
1 11 1 1 3.0 1.5 1.00 100.63 
2 12 1 1 3.0 3.0 0.25 90.14 
 
Table 2: Factorial design of formulations by applying Central composite Formulation design 








6 1 -1 1 3.517 1.125 57.7 70.6 
4 2 1 1 3.000 2.000 68.4 82.1 
1 3 1 1 0.500 0.250 69.0 82.7 
11 4 0 1 1.750 1.125 58.5 72.4 
9 5 0 1 1.750 1.125 47.5 67.4 
12 6 0 1 1.750 1.125 70.8 92.7 
10 7 0 1 1.750 1.125 69.8 90.5 
2 8 1 1 3.000 0.250 80.2 98.6 
3 9 1 1 0.500 2.000 70.1 85.8 
5 10 -1 1 -0.017 1.125 111.2 111.2 
8 11 -1 1 1.750 2.362 61.2 84.2 
7 12 -1 1 1.750 -0.114 103.3 103.3 
13 13 0 1 1.750 1.125 68.3 89.9 
 
Evaluation of in-situ gel formulations 
The prepared in situ gel was evaluated for the following parameters. 
Physical appearance and pH 
In situ solutions should be clear and free of any particulate matter. 
All the formulations were checked visually for clarity. Also the 
consistency of the gel formed was checked visually. The pH of gel 
forming solution was measured using calibrated pH meter at 25oC. 
In vitro floating ability 
The In vitro floating study was carried out using 0.1N HCl (pH 1.2). 
The medium temperature was maintained at 37±0.5°C. 10 ml of 
formulation was introduced into the dissolution vessel containing 
medium without much disturbance. The time the formulation had 
taken to emerge on the medium surface (floating lag time) and the 
time the formulation constantly floated on the surface of the 
dissolution medium (duration of floating) was noted.  
In vitro drug release 
The release rate of drug from in situ gel was determined using USP 
dissolution rate testing apparatus I (basket covered with muslin 
cloth) at 50 rpm. [5, 6, 7] 900 ml of 0.1N HCl was used as the 
dissolution medium and temperature of 37±0.5o C was maintained. 
10 ml samples were withdrawn at the interval of 1 hour for 
estimating the drug release using UV-Visible spectrophotometer. 
Same volume of fresh medium was replaced every time the sample 
had been withdrawn. Dissolution study was carried out for 8 hours. 
Mathematical analysis of In vitro drug release studies 
The drug release profiles of various formulations were compared 
mathematically using similarity factor (f2) and dissimilarity factor 
(f1) given by SUPAC guidelines [8]. The f2 value between 50 to100 
indicates similarity between two dissolution profiles. The drug 
release kinetics were determined by fitting cumulative amount of 
drug release at different time intervals into the equation of zero 
order. First order, Higuchi and Krosmeyer Peppas model. 
Statistical analysis of data 
The software used for statistical analysis of data were Microsoft 
Excel 2013 and Minitab 16. Also chi-square test had been applied to 
detect the goodness of fit between optimized batch and predicted 
values. 
RESULTS AND DISCUSSION 
Experimental design 
Preliminary trials 
Preliminary trials were conducted using various gelling agents like 
sodium alginate and pectin and crosslinking agents like calcium 
carbonate, calcium chloride and sodium bicarbonate to find out the 
appropriate gelling agent and cross linking agent by determining the 
floating properties. With sodium alginate alone gelling and floating 
were not observed. On addition of calcium carbonate floating took 
place within few seconds and stiff gel was formed. With sodium 
bicarbonate, the gel was able to float but the gel so formed was not 
stiff. Thus sodium alginate and pectin were chosen as gelling agents 
and calcium carbonate as crosslinking agent for the further studies. 
On addition of sodium citrate to the previous formulations, no 
significant effect was observed. But it forms complex with all the 
Calcium ions present in the formulation maintaining the fluidity of 
the solution and hence preventing the formation of gel before 
administration [9,10]. 
Plackett-burman design 
Twelve formulations were developed from Plackett-Burman design 
in Minitab 16 constituting sodium alginate, pectin and calcium 
carbonate as variables and ranitidine and sodium citrate as 
constants. The formulations were evaluated for In vitro drug release 
at 4 hours. The effect of sodium alginate was found to be 7.428 while 
the effect of pectin was found to be 6.892. Also from main effect plot 
figure 1, it was observed that the effect of sodium alginate was found 
to be more than that of pectin. Thus pectin was dropped and sodium 
alginate and calcium carbonate were chosen for further studies. 
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Fig. 1: Main effects plot of Plackett-Burman formulations 
 
Central composite design 
The central composite design was used in Minitab 16 to develop 13 
formulations using two independent variables sodium alginate (0.5-
3% w/v) as gelling agent and calcium carbonate (0.25-2% w/v) as 
crosslinking agent. All the formulations contained 1.68 g of sodium 
alginate and 0.25% w/v of sodium citrate as constant. The drug 
release at 4 hours (Q4hr) and 8 hour (Q8hr) was used as dependent 
variables. 
In vitro evaluation of buoyancy 
When the formulations comes in contact with an acidic medium, 
gelation and cross-linking by Ca++ ions occurs to provide a gel 
barrier at the surface of the formulation. Calcium carbonate 
demonstrated effervescence effect releasing carbon dioxide and 
calcium ions. The released carbondioxide is entrapped in the gel 
network resulting in buoyant formulation and then calcium ions 
react with alginate to produce a crosslinked three dimensional gel 
network which restrict the further diffusion of carbondioxide and 
drug molecules and thus resulting in extended period of floating and 
drug release, respectively [7, 11, 12]. The excellent floating time of 
more than 24 hours was demonstrated by all the formulations 
except formulation F10 and F12 which were not able to float due to 
the lack of gelation due to the absence of sodium alginate in former 
and calcium carbonate in latter. In these two formulations, the gel 
settled at the bottom of the medium. 
 
 
Fig. 2: Bar diagram for floating lag time 
 
Effect of Calcium carbonate concentration on floating of gel 
Although as discussed previously that calcium carbonate plays an 
important role in floating of the gel, it was observed that the 
concentration of calcium carbonate did not affect the floating lag 
time of the formulations. As shown in figure 2, the floating lag time 
for the formulations F2 and F8, F3 and F9 and F11 and F13 that 
contained equal amount of SA but different concentrations of 
calcium carbonate was found to be nearly same. 
Effect of Sodium alginate concentration on floating of gel 
On comparison of F2 and F9 where both contained 2% w/v of 
calcium carbonate, the floating lag time was more in F2 than in F9. 
This was due to higher concentration of sodium alginate in F2 which 
made the gel heavier and thus increasing the floating lag time. 
Similar effect was observed in between F1 and F13 and then in F3 
and F8. This might be because the gel formed from in situ gelling 
system, being lighter than gastric fluids, floats over the stomach [3]. 
In vitro drug release studies 
The release profiles of Ranitidine in situ gel showed initial rapid 
release (burst effect) followed by slow and gradual release. The 
initial release ranged from 24% to 53.2% within one hour which 
might be due to high solubility of ranitidine in 0.1M HCl. Another 
reason might be that the formulation being in solution form, the 
surface deposited drugs dissolves in the HCl before formation of gel. 
Similar result was discussed by Bihami et. al. where the release of 
drug from the gel was characterized by an initial phase of high 
release (burst effect). As gelation progresses, the remaining drug 
was released at slower rate followed by a second phase of moderate 
release. This bi-phasic pattern of release is a characteristic feature of 
matrix diffusion kinetics [12].  
The formulation F12 that contained only sodium alginate showed 
the lack of any sustained release owing to the complete release of 
drug 101.4% at the end of one hour indicating that sodium alginate 
alone cannot control the release of drug. This might be because in 
absence of calcium carbonate there was no crosslinking resulting in 
no gel formation. Similar effect was observed in the study done by S. 
Miyazaki et. al. where lack of sustained release of theophylline by 
the soft alginic acid gels formed in absence of Ca++ ions [9]. The 
formulation F10 also showed complete release of ranitidine 
(110.6%) that contained calcium carbonate only and deprived of 
sodium alginate. 
The release was highest in the formulation F8 which contained 3% 
w/v sodium alginate and 0.25% w/v calcium carbonate. The amount 
of sodium alginate was greater than the amount of calcium 
carbonate (SA: CaCO3::12:1) due to which insufficient cross linking 
between sodium alginate and calcium carbonate occurred.  
 
 
Fig. 3: In vitro drug release profiles 
 
Effect of Calcium carbonate concentration on drug release 
On comparison of formulation F2 and F8, the release was more in 
the formulation F8 as it contained lesser concentration of calcium 
carbonate than F2 while concentration of sodium alginate was same 
in both formulations. This is because calcium carbonate being the 
cross linking agent, crosslinks with the sodium alginate forming gel 
and thus entrapping the drug within. As concentration of calcium 
carbonate was higher in F2, more crosslinking occurred and lesser 
release of drug as shown in figure 3. Similar effect was observed in 
the formulation F11 and F13, the release was higher in F13 which 
contained 1.125% w/v of calcium carbonate than in F11 which 
contained 2.362% w/v as show in figure 3. 
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Effect of Sodium alginate concentration on drug release 
The release was found to be higher in the formulation F13 
containing 1.75% w/v of sodium alginate that F1 containing 3.517% 
w/v sodium alginate and both formulations contained the same 
concentration of calcium carbonate. This is because sodium alginate 
forms gel in the presence of Ca++, and the greater quantity of gelling 
agent forms more gel.  
The decrease in the rate and extent of drug release was observed 
with the increase in polymer concentration and is attributed to 
increase in the density of the polymer matrix and also an increase in 
the diffusional path length which the drug molecules have to cross. 
Similar effect was observed in the study conducted by Miyazaki S. et 
al. Where the decrease of percentage release of theophylline from 
the alginate gels with the increase of alginate concentration [9]. 
Drug release kinetics 
In order to investigate the mode of drug release from the in situ gels, 
the drug release data were analyzed using mathematical models: 
zero order kinetics, first order kinetics, Higuchi equation and 
Krosmeyer Peppas model. The R2 value indicated that all the 
formulations followed Krosmeyer Peppas model of drug release 
except F13 which followed Higuchi model.  
Krosmeyer Peppas model as the release mechanism was also found 
in the study done by Patel J. K. et. al.[13] The n value was found to be 
<0.45 except the formulation F5 where n= 0.518, indicating that all 
the formulations follow Fickian diffusion while F5 follows non-
fickian diffusion. 
Optimization of batch 
For the optimization of 50-60% drug release at 4 hours and 80-
100% drug release at 8 hours [4, 13, 14] the concentration of 
sodium alginate (X1) and calcium carbonate (X2) was taken as 
independent variables and the cumulative percentage release at 4 hr 
and 8 hr as dependent variables for the experiment design. The 
overlaid contour plot for the release at 4 hr and 8 hr was plotted as 
shown in figure 4 by using Minitab 16. 
 
 
Fig. 4: Over laid contour plot for the release at 4 hr and 8 hr 
 
Factorial equation for Q4hr 
The polynomial equation developed for drug release at 4 hrs was 
𝑌𝑌 = 106.689− 20.947 𝑋𝑋1 − 24.795𝑋𝑋2 + 5.042𝑋𝑋12 + 8.854𝑋𝑋22
− 2.949𝑋𝑋1𝑋𝑋2 
The above equation represents the quantitative effect of process 
variables, X1 (concentration of sodium alginate) and X2 
(concentration of calcium carbonate), and their interactions on the 
response Y (drug release at 4 hr). A positive sign represents the 
synergistic effect while negative sign indicates antagonistic effect. 
The values of X1 and X2 were substituted in the equation to obtain the 
predicted value of Y. From overlaid contour plot when the value of 
X1 and X2 were with 1.898 and 1.852, the value of Y for Q4hr was 
found to be 59.17%. 
 
Fig. 5: Contour plot showing effect of X1 and X2 on Q4hr 
 
Factorial equation for Q8hr 
The polynomial equation developed for drug release at 8 hrs was 
𝑌𝑌 = 101.015− 5.986 𝑋𝑋1 − 10.654 𝑋𝑋2 + 1.858 𝑋𝑋12 + 5.653𝑋𝑋22
− 4.48 𝑋𝑋1𝑋𝑋2 
The above equation represents the quantitative effect of process 
variables, X1 (concentration of sodium alginate) and X2 
(concentration of calcium carbonate), and their interactions on the 
response Y (drug release at 8 hr). From overlaid contour plot when 
the value of X1 and X2 was substituted with 1.898 and 1.852, the 
value of Y for Q8hr was found to be 80.26%. 
 
 
Fig. 6: Contour plot showing effect of X1 and X2 on Q8hr 
 
The optimized batch was formulated using 1.898% w/v of sodium 
alginate and 1.852% w/v of calcium carbonate as indicated by 
overlaid contour plot shown in figure 4. This formulation was 
analyzed for In vitro drug release and floating time. The floating lag 
time was found to be 59 sec and the floating time was more than 24 
hours which indicated the good floating properties. On comparing 
the cumulative % release of optimized formulation with the 
predicted value at 4hr and 8hr, the similarity factor was found to be 
88.41 that indicate the good similarity between them.  
Chi-square test of optimized batch 
The hypothesis was developed for optimized batch as following, 
µo: observed value is close to predicted value 
µ1: observed value is not close to predicted value 
The chi-square value was calculated to be 0.047 which is less than 
critical chi-square value 3.841 (at degree of freedom = 1 and 
confidence interval = 95%) indicating that the null hypothesis is 
true. The p-value was found to be 0.99 and the percentage error 
was calculated to be 0.02%. Since a p-value is greater than the 
conventionally accepted significance level of 0.05 (i. e. p > 0.05) 
we fail to reject the null hypothesis. Thus, goodness of fit between 
the observed value of optimized batch and predicted value is 
significant. 
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The In vitro drug release profile demonstrated the positive effect of 
concentration of both SA and CaCO3 on comparing various 
formulations. It was also found that the ratio of SA and CaCO3 also 
affects the release pattern. All the formulations were found to follow 
Krosmeyer Peppas model except F13 that followed Higuchi model. 
The present study showed that the floating in situ gel can be 
prepared using sodium alginate as gelling agent and calcium 
carbonate as crosslinking agent. With the suitable concentration of 
SA and CaCO3, the sustained release of the drug can be achieved by 
in situ gel along with good floating properties. Thus, this approach 
provides a potential development of sustained release floating in 
situ system of the liquid preparations. 
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